Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.
Giant cell arteritis (GCA) and Takayasu's disease are inflammatory vasculitic syndromes (IVS) causing sudden blindness and widespread arterial obstruction and aneurysm formation. Glucocorticoids and aspirin are mainstays of treatment, predominantly targeting T cells. Serp-1, a Myxomavirus-deriv...
Main Authors: | Hao Chen, Donghang Zheng, Sriram Ambadapadi, Jennifer Davids, Sally Ryden, Hazem Samy, Mee Bartee, Eric Sobel, Erbin Dai, Liying Liu, Colin Macaulay, Anthony Yachnis, Cornelia Weyand, Robert Thoburn, Alexandra Lucas |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4319900?pdf=render |
Similar Items
-
Innate and Adaptive Immunity in Giant Cell Arteritis
by: Mitsuhiro Akiyama, et al.
Published: (2021-02-01) -
Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.
by: Kasinath Viswanathan, et al.
Published: (2012-01-01) -
Study of Substituted Benzenesulfonate-Containing Layered Double Hydroxides and Investigation of the Hexamethylenetetramine Route of LDH Synthesis
by: Ambadapadi, Sriram
Published: (2007) -
Combined bilateral ophthalmic artery occlusion & central retinal vein occlusion from presumed giant cell arteritis
by: Mark Hankins, et al.
Published: (2018-12-01) -
Giant Cell Arteritis versus Takayasu Arteritis: An Update
by: Pavlos Stamatis
Published: (2020-01-01)